lemme glp-1 GLP‑1 Daily 37399915_web1_M1-FWM20240917-Lemme-GLP-1-Daily–Teaser | Federal Way Mirror
Description
The scale barely changes
Koye DN, Ling J, Dibato J, Khunti K, Montvida O, Paul SK (2020) Temporal trend in young-onset type 2 diabetesmacrovascular and mortality risk: study of UK primary care electronic medical records
Large cardiovascular outcome trials consistently show fewer heart attacks and strokes with GLP-1 use
The three pathways work in concert rather than competition
McGraw-Hill / Lange rxlist.com (Onglyza ) Keywords Linagliptin Trade Name: Tragenta Drug Class: oral hypoglycemics Mechanism of Action: An inhibitor of dipeptidyl peptidase-4 (DPP-4), a protease that degrades the incretin GLP-1 Pharmacokinetics: biliary tract excretion - unique elimination route amongst the DPP-4 inhibitors useful for Type II diabetic patients with reduced renal function
